Product Code: 5341
The global blood group typing market is poised to record significant growth through 2030. A sustainable rise in the number of road accidents and emergencies has elevated the need for blood transfusion and related blood group typing tests.
Ongoing blood shortages experienced by countries worldwide have supported new blood campaigns and donation drives. For instance, in September 2022, the Health Ministry of India announced a nationwide blood donation campaign to overcome the blood supply and demand disparity in the country.
Technological advancements in genetic engineering will advocate the introduction of RBC-based antigen genotyping that relies on next-generation sequencing (NGS) and high-density DNA arrays. In March 2022, Immucor launched MIA FOR A NGS EXPRESS, its latest HLA typing software to provide a value-added user experience to its customers. The new tool is designed to facilitate high-accuracy antigen typing capable of addressing the limitations of existing NGS products used in laboratories.
The blood group typing market is categorized into components, technique, test type, end-use, and region.
Based on component, the market is fragmented into consumables, services, and instruments. Among these, the service segment is projected to reach over USD 300 million through 2030. The availability of a range of blood group typing services enables accurate and faster analysis with the help of state-of-the-art software technologies. Software-integrated service enhances overall patient experience with improved clinical processes.
In terms of technique, the blood group typing industry is classified into next-generation sequencing (NGS), assay-based, PCR-based & microarray, and others. Next-generation sequencing (NGS) segment is expected to exhibit substantial growth from 2022-2030 owing to widespread usage in a variety of tests. NGS helps determine blood group antigens based on certain specific gene sequences.
By test type, the industry is bifurcated into ABO tests, antigen typing, cross-matching tests, antibody screening & identification, and others. Among these, antibody screening & identification, also known as antibody detection test, is applied to identify whether foreign antibodies or non-ABO antibodies are present/absent in the blood.
With respect to end-use, the blood group typing market is divided into blood banks, hospitals, laboratories, and others. In 2021, the hospitals segment held over 50% of the overall market share. High preference for hospitalized treatment among geriatric patients and individuals is expected to complement the segment growth.
Latin America blood group typing market valuation surpassed USD 150 million in 2021. Increasing focus on strengthening blood supply and growing number of blood donation drives and campaigns will foster business expansion. LATAM countries including Brazil, El Salvador, Peru, Uruguay, and Ecuador joined the Worldwide Blood Drive started by Intl. WeLoveU Foundation with the aim of addressing blood supply shortages intensified by the COVID-19 pandemic.
Table of Contents
Chapter 1 Methodology & Scope
- 1.1 Market definitions
- 1.2 Base estimates & working
- 1.2.1 North America
- 1.2.2 Europe
- 1.2.3 Asia Pacific
- 1.2.4 Latin America
- 1.2.5 Middle East & Africa
- 1.3 Forecast parameters
- 1.4 Data validation
- 1.5 Data sources
- 1.5.1 Secondary
- 1.5.1.1 Paid sources
- 1.5.1.2 Public sources
- 1.5.2 Primary
Chapter 2 Executive Summary
- 2.1 Blood group typing industry 360 degree synopsis, 2017 - 2030
- 2.1.1 Business trends
- 2.1.2 Components trends
- 2.1.3 Technique trends
- 2.1.4 Test type trends
- 2.1.5 End-use trends
- 2.1.6 Regional trends
Chapter 3 Blood Group Typing Industry Insights
- 3.1 Industry segmentation
- 3.2 Industry landscape, 2017 - 2030
- 3.3 Industry impact forces
- 3.3.1 Growth drivers
- 3.3.1.1 Growing number of road accidents, emergenices and trauma cases necessitating blood transfusion
- 3.3.1.2 Several blood donation campaigns undertaken by various organization
- 3.3.1.3 Increasing demand for blood group typing in prenatal testing
- 3.3.2 Industry pitfalls & challenges
- 3.3.2.1 Increasing prevalence of Transfusion Transmitted Infections (TTIs)
- 3.4 Growth potential analysis
- 3.4.1 By components
- 3.4.2 By technique
- 3.4.3 By test type
- 3.4.4 By end-use
- 3.5 COVID- 19 impact analysis
- 3.6 Regulatory landscape
- 3.6.1 North America
- 3.6.2 Europe
- 3.6.3 Asia Pacific
- 3.7 Technology landscape
- 3.8 Blood type compatibility landscape
- 3.9 Porter's analysis
- 3.9.1 Bargaining power of suppliers
- 3.9.2 Bargaining power of buyers
- 3.9.3 Threat of new entrants
- 3.9.4 Threat of substitutes
- 3.10 Competitive landscape, 2021
- 3.10.1 Global company market share analysis, 2021
- 3.10.2 Company matrix analysis, 2021
- 3.11 PESTLE analysis
- 3.11.1 Political
- 3.11.2 Economic
- 3.11.3 Social
- 3.11.4 Technological
- 3.11.5 Environmental
- 3.11.6 Legal
Chapter 4 Blood Group Typing Market, By Components
- 4.1 Key segment trends
- 4.2 Consumables
- 4.2.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.3 Instruments
- 4.3.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.4 Services
- 4.4.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 5 Blood Group Typing Market, By Technique
- 5.1 Key segment trends
- 5.2 PCR-based & Microarray
- 5.2.1 Market size, by region, 2017 - 2030 (USD Million)
- 5.3 Assay-based
- 5.3.1 Market size, by region, 2017 - 2030 (USD Million)
- 5.4 Next Generation Sequencing (NGS)
- 5.4.1 Market size, by region, 2017 - 2030 (USD Million)
- 5.5 Other
- 5.5.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 6 Blood Group Typing Market, By Test Type
- 6.1 Key segment trends
- 6.2 Antigen typing
- 6.2.1 Market size, by region, 2017 - 2030 (USD Million)
- 6.3 Anitbody screening & identification
- 6.3.1 Market size, by region, 2017 - 2030 (USD Million)
- 6.4 ABO Tests
- 6.4.1 Market size, by region, 2017 - 2030 (USD Million)
- 6.5 Cross-matching Tests
- 6.5.1 Market size, by region, 2017 - 2030 (USD Million)
- 6.6 Other
- 6.6.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 7 Blood Group Typing Market, By End-use
- 7.1 Key segment trends
- 7.2 Hospitals
- 7.2.1 Market size, by region, 2017 - 2030 (USD Million)
- 7.3 Laboratories
- 7.3.1 Market size, by region, 2017 - 2030 (USD Million)
- 7.4 Blood banks
- 7.4.1 Market size, by region, 2017 - 2030 (USD Million)
- 7.5 Others
- 7.5.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 8 Blood Group Typing Market, By Region
- 8.1 Key regional trends
- 8.2 North America
- 8.2.1 Market size, by country, 2017 - 2030 (USD Million)
- 8.2.2 Market size, by components, 2017 - 2030 (USD Million)
- 8.2.3 Market size, by technique, 2017 - 2030 (USD Million)
- 8.2.4 Market size, by test type, 2017 - 2030 (USD Million)
- 8.2.5 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.2.6 U.S.
- 8.2.6.1 Market size, by components, 2017 - 2030 (USD Million)
- 8.2.6.2 Market size, by technique, 2017 - 2030 (USD Million)
- 8.2.6.3 Market size, by test type, 2017 - 2030 (USD Million)
- 8.2.6.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.2.7 Canada
- 8.2.7.1 Market size, by components, 2017 - 2030 (USD Million)
- 8.2.7.2 Market size, by technique, 2017 - 2030 (USD Million)
- 8.2.7.3 Market size, by test type, 2017 - 2030 (USD Million)
- 8.2.7.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.3 Europe
- 8.3.1 Market size, by country, 2017 - 2030 (USD Million)
- 8.3.2 Market size, by components, 2017 - 2030 (USD Million)
- 8.3.3 Market size, by technique, 2017 - 2030 (USD Million)
- 8.3.4 Market size, by test type, 2017 - 2030 (USD Million)
- 8.3.5 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.3.6 Germany
- 8.3.6.1 Market size, by components, 2017 - 2030 (USD Million)
- 8.3.6.2 Market size, by components, 2017 - 2030 (USD Million)
- 8.3.6.3 Market size, by test type, 2017 - 2030 (USD Million)
- 8.3.6.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.3.7 UK
- 8.3.7.1 Market size, by components, 2017 - 2030 (USD Million)
- 8.3.7.2 Market size, by technique, 2017 - 2030 (USD Million)
- 8.3.7.3 Market size, by test type, 2017 - 2030 (USD Million)
- 8.3.7.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.3.8 France
- 8.3.8.1 Market size, by components, 2017 - 2030 (USD Million)
- 8.3.8.2 Market size, by technique, 2017 - 2030 (USD Million)
- 8.3.8.3 Market size, by test type, 2017 - 2030 (USD Million)
- 8.3.8.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.3.9 Spain
- 8.3.9.1 Market size, by components, 2017 - 2030 (USD Million)
- 8.3.9.2 Market size, by technique, 2017 - 2030 (USD Million)
- 8.3.9.3 Market size, by test type, 2017 - 2030 (USD Million)
- 8.3.9.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.3.10 Italy
- 8.3.10.1 Market size, by components, 2017 - 2030 (USD Million)
- 8.3.10.2 Market size, by technique, 2017 - 2030 (USD Million)
- 8.3.10.3 Market size, by test type, 2017 - 2030 (USD Million)
- 8.3.10.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.4 Asia Pacific
- 8.4.1 Market size, by country, 2017 - 2030 (USD Million)
- 8.4.2 Market size, by components, 2017 - 2030 (USD Million)
- 8.4.3 Market size, by technique, 2017 - 2030 (USD Million)
- 8.4.4 Market size, by test type, 2017 - 2030 (USD Million)
- 8.4.5 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.4.6 Japan
- 8.4.6.1 Market size, by components, 2017 - 2030 (USD Million)
- 8.4.6.2 Market size, by technique, 2017 - 2030 (USD Million)
- 8.4.6.3 Market size, by test type, 2017 - 2030 (USD Million)
- 8.4.6.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.4.7 China
- 8.4.7.1 Market size, by components, 2017 - 2030 (USD Million)
- 8.4.7.2 Market size, by technique, 2017 - 2030 (USD Million)
- 8.4.7.3 Market size, by test type, 2017 - 2030 (USD Million)
- 8.4.7.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.4.8 India
- 8.4.8.1 Market size, by components, 2017 - 2030 (USD Million)
- 8.4.8.2 Market size, by technique, 2017 - 2030 (USD Million)
- 8.4.8.3 Market size, by test type, 2017 - 2030 (USD Million)
- 8.4.8.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.4.9 Australia
- 8.4.9.1 Market size, by components, 2017 - 2030 (USD Million)
- 8.4.9.2 Market size, by technique, 2017 - 2030 (USD Million)
- 8.4.9.3 Market size, by test type, 2017 - 2030 (USD Million)
- 8.4.9.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.5 Latin America
- 8.5.1 Market size, by country, 2017 - 2030 (USD Million)
- 8.5.2 Market size, by components, 2017 - 2030 (USD Million)
- 8.5.3 Market size, by technique, 2017 - 2030 (USD Million)
- 8.5.4 Market size, by test type, 2017 - 2030 (USD Million)
- 8.5.5 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.5.6 Brazil
- 8.5.6.1 Market size, by components, 2017 - 2030 (USD Million)
- 8.5.6.2 Market size, by technique, 2017 - 2030 (USD Million)
- 8.5.6.3 Market size, by test type, 2017 - 2030 (USD Million)
- 8.5.6.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.5.7 Mexico
- 8.5.7.1 Market size, by components, 2017 - 2030 (USD Million)
- 8.5.7.2 Market size, by technique, 2017 - 2030 (USD Million)
- 8.5.7.3 Market size, by test type, 2017 - 2030 (USD Million)
- 8.5.7.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.6 Middle East and Africa
- 8.6.1 Market size, by country, 2017 - 2030 (USD Million)
- 8.6.2 Market size, by components, 2017 - 2030 (USD Million)
- 8.6.3 Market size, by technique, 2017 - 2030 (USD Million)
- 8.6.4 Market size, by test type, 2017 - 2030 (USD Million)
- 8.6.5 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.6.6 South Africa
- 8.6.6.1 Market size, by components, 2017 - 2030 (USD Million)
- 8.6.6.2 Market size, by technique, 2017 - 2030 (USD Million)
- 8.6.6.3 Market size, by test type, 2017 - 2030 (USD Million)
- 8.6.6.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.6.7 Saudi Arabia
- 8.6.7.1 Market size, by components, 2017 - 2030 (USD Million)
- 8.6.7.2 Market size, by technique, 2017 - 2030 (USD Million)
- 8.6.7.3 Market size, by test type, 2017 - 2030 (USD Million)
- 8.6.7.4 Market size, by end-use, 2017 - 2030 (USD Million)
Chapter 9 Company Profiles
- 9.1 Competitive dashboard, 2021
- 9.2 Grifols
- 9.2.1 Business Overview
- 9.2.2 Financial Data
- 9.2.3 Product Landscape
- 9.2.4 Strategic Outlook
- 9.2.5 SWOT Analysis
- 9.3 Ortho Clinical Diagnostics
- 9.3.1 Business Overview
- 9.3.2 Financial Data
- 9.3.3 Product Landscape
- 9.3.4 Strategic Outlook
- 9.3.5 SWOT Analysis
- 9.4 Immucor
- 9.4.1 Business Overview
- 9.4.2 Financial Data
- 9.4.3 Product Landscape
- 9.4.4 Strategic Outlook
- 9.4.5 SWOT Analysis
- 9.5 Quotient
- 9.5.1 Business Overview
- 9.5.2 Financial Data
- 9.5.3 Product Landscape
- 9.5.4 Strategic Outlook
- 9.5.5 SWOT Analysis
- 9.6 BAG GROUP DIAGNOSTICS
- 9.6.1 Business Overview
- 9.6.2 Financial Data
- 9.6.3 Product Landscape
- 9.6.4 Strategic Outlook
- 9.6.5 SWOT Analysis
- 9.7 Bio-Rad Laboratories
- 9.7.1 Business Overview
- 9.7.2 Financial Data
- 9.7.3 Product Landscape
- 9.7.4 Strategic Outlook
- 9.7.5 SWOT Analysis
- 9.8 Agena Biosciences Inc
- 9.8.1 Business Overview
- 9.8.2 Financial Data
- 9.8.3 Product Landscape
- 9.8.4 Strategic Outlook
- 9.8.5 SWOT Analysis
- 9.9 Thermo Fisher Scientific (One Lambda, Inc)
- 9.9.1 Business Overview
- 9.9.2 Financial Data
- 9.9.3 Product Landscape
- 9.9.4 Strategic Outlook
- 9.9.5 SWOT Analysis
- 9.10 Danaher (Beckman Coulter)
- 9.10.1 Business Overview
- 9.10.2 Financial Data
- 9.10.3 Product Landscape
- 9.10.4 Strategic Outlook
- 9.10.5 SWOT Analysis
- 9.11 Rapid Labs Ltd
- 9.11.1 Business Overview
- 9.11.2 Financial Data
- 9.11.3 Product Landscape
- 9.11.4 Strategic Outlook
- 9.11.5 SWOT Analysis